SCHEMBL4933959

SCHEMBL4933959

O=C(O)CNC(=O)c1cc(Cl)c(OCc2cc(Cl)cc(NC3CCC3)c2F)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
HSD17B10 Q99714 1/20 0.34
USP5 P45974 4/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ABL1 P00519 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
RIN1 Q13671 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DDR1 Q08345 4/20 0.32
TAOK1 Q7L7X3 1/20 0.32
TAOK3 Q9H2K8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717783 0.95 PTGDR (0.34) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL4924159 0.92 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4922902 0.91 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL4929630 0.88 SUCNR1 (0.39) PDE4APDE4BPDE4CPDE4DUSP5
SCHEMBL5717790 0.87 KMT2A (0.32) HSD17B10MEN1GAAMAPTKMT2A
SCHEMBL5718149 0.86 PDE4A (0.34) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL4927388 0.85 GPR139 (0.38) HSD17B10MEN1ALDH1A1ABL1LMNA
SCHEMBL4932686 0.84 THRB (0.37) MEN1ALDH1A1GAAMAPTKMT2A
SCHEMBL4931803 0.84 ALDH1A1 (0.38) HSD17B10MEN1ALDH1A1ABL1LMNA
SCHEMBL5718084 0.83 SUCNR1 (0.39) PDE4APDE4BPDE4CPDE4DMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA PDE4A 897/4885PDE4B 1391/4885PDE4C 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.